151
Participants
Start Date
October 31, 2021
Primary Completion Date
June 30, 2024
Study Completion Date
July 12, 2024
Licart™ (diclofenac epolamine) topical system
The Licart™ (diclofenac epolamine) topical system was designed to deliver the nonsteroidal anti-inflammatory drug (NSAID) diclofenac to the site of a minor soft tissue injury through topical application. This investigational product (IP) is a 10 cm x 14 cm topical system comprised of an adhesive material containing 1.3% diclofenac epolamine that is bound to a non-woven polyester felt backing and covered with a polypropylene film release liner. The release liner is removed prior to topical application to the skin.
Prime Global Research Inc., The Bronx
Ascendant Research Clinic, LLC., Marion
University Clinical Research - Deland, LLC, DeLand
My Community Research, Inc., Miami
D & H Tamarac Research Centers, Inc., Tamarac
Research Integrity, Owensboro
Applied Research Center, Little Rock
AIM Trials, Plano
Next Level Urgent Care, Houston
Ascendant Research Clinic, LLC., Alamogordo
Atella Clinical Research, LLC., La Palma
Lead Sponsor
IBSA Institut Biochimique SA
INDUSTRY